Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)
Author:
Sereti Irini, Shaw-Saliba Kathryn, Dodd Lori E., Dewar Robin L., Laverdure Sylvain, Brown Shawn, Mbaya Olivier Tshiani, Muyembe Tamfum Jean Jacques, Mblala-Kingebeni Placide, Sow Ydrissa, Akpa Esther, Haidara Mory Cherif, Fouth Tchos Karine, Beavogui Abdoul Habib, Neal Aaron, Arlinda Dona, Lokida Dewi, Grue Louis, Smolskis Mary, McNay Laura A., Gayedyu-Dennis Dehkontee, Ruiz-Palacios Guillermo M., Montenegro-Liendo Abelardo, Tounkara Moctar, Samake Seydou, Jargalsaikhan Ganbolor, Zulkhuu Delgersaikhan, Weyers Shera, Bonnett Tyler, Potter Gail E., Stevens Randy, Rupert Adam, Aboulhab Jamila, Biampata Jean-Luc, Delamo Alexandre, Camara Bienvenu Salim, Kosasih Indonesia Herman, Karyana Muhammad, Duworko James T., Regalado-Pineda Justino, Guerra-de-Blas Paola del Carmen, Doumbia Seydou, Dabitao Djeneba, Dashdorj Naranjargal, Dashdorj Naranbaatar, Newell Kevin, Francis Alyson, Rubenstein KevinORCID, Bera Victoria, Gulati Iman, Sardana Ratna, Millard Monica, Ridzon ReneeORCID, Hunsberger Sally
Abstract
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Funder
National Cancer Institute, National Institutes of Health
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference14 articles.
1. WHO. WHO Coronavirus (COVID-19) Dashboard 2022 [Available from: https://covid19.who.int. 2. WHO. Coronavirus disease (COVID-19): Vaccines 2021 [updated 19 February 2021. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines. 3. WHO. Landscape of observational studies on the effectiveness of COVID-19 vaccination 2022 [Available from: https://www.who.int/publications/m/item/draft-landscape-of-observational-study-designs-on-the-effectiveness-of-covid-19-vaccination. 4. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.;NJ Dashdorj;Cell Host & Microbe,2021 5. Suppression of vaccine responses by malaria: insignificant or overlooked?;AJ Cunnington;Expert Rev Vaccines,2010
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|